ADAM10 and cancer: Our future will screen more small molecules by molecular docking simulations and/or experimental validation for inhibiting ADAM10 expression and investigating the resulting mechanism, such as DNA/RNA G-quadruplex modification, that may develop a potential therapeutic strategy for anti-cancer.